Asmin 4mg Tablet

Asmin 4mg Tablet contains Montelukast 4mg, a leukotriene receptor antagonist formulated at a lower paediatric strength intended for young children, generally around 2 to 5 years of age, who have been diagnosed with asthma or, in some cases, allergic rhinitis. It works by blocking leukotrienes, natural chemicals in the body that contribute to airway inflammation, narrowing, and mucus production, helping to reduce how often asthma symptoms occur and easing allergy-related breathing or nasal difficulties in this younger age group.

Asmin 4mg Tablet is a prescription-only medicine in Malaysia. DoctorOnCall requires an online medical consultation so a doctor can assess the child’s diagnosis, age, and weight before a prescription is issued and the medicine is dispensed by a registered pharmacist.

Montelukast selectively blocks the cysteinyl leukotriene receptor (CysLT1) on airway tissue, preventing leukotrienes from triggering inflammation, swelling, and constriction of the small airways. By interrupting this pathway, it helps keep a young child’s airways calmer and less reactive to common asthma triggers over time, functioning as a preventive maintenance treatment rather than a fast-acting rescue medicine.

Asmin 4mg Tablet is usually given once daily in the evening, as prescribed by the child’s doctor, and depending on its exact formulation may be chewable, dispersible, or intended to be given with food or liquid; follow the pharmacist’s specific instructions for administering it to a young child. It should be given consistently every day, even when the child appears well, unless the doctor advises otherwise.

The 4mg strength is intended for young children within the age range specified by the prescribing doctor, generally around 2 to 5 years, and the exact dose and duration should follow the doctor’s instructions precisely. This medicine does not relieve a sudden asthma attack, so a reliever inhaler should still be available as directed by the child’s doctor.

Asmin 4mg Tablet should be used within the shelf life printed on the packaging when stored correctly. Do not use the tablets after the expiry date shown on the box, and any unused or expired medicine should be disposed of safely.

Store Asmin 4mg Tablet at room temperature, away from direct light, heat, and moisture, in its original packaging until it is time for the next dose. Keep the medicine well out of the reach of children, as young-child formulations can sometimes be mistaken for sweets.

• Known hypersensitivity to montelukast or any ingredient in the tablet
• Not intended for relief of acute asthma attacks or status asthmaticus
• Use with caution in children with a history of mental health or behavioural changes, and report any new mood or behaviour symptoms to the doctor
• Should not replace other prescribed asthma medicines without the doctor’s specific instruction
• Use only under medical guidance if the child has liver impairment

• May interact with certain enzyme-inducing medicines such as phenobarbital or rifampicin, which can reduce montelukast’s effect
• Inform the doctor of all other medicines, including other asthma or allergy treatments, the child is taking
• No significant food restrictions are required, and it can be taken with or without meals as directed
• Do not combine with other leukotriene modifiers unless specifically directed by the doctor

• Give the dose at the same time each evening to build a consistent routine
• Continue giving this medicine daily even when the child has no symptoms, unless the doctor says to stop
• Always keep a reliever inhaler available as prescribed, since this medicine does not treat sudden attacks
• Watch for and report any unusual mood, behaviour, or sleep changes to the doctor
• Keep all scheduled follow-up appointments to monitor the child’s asthma control
• Store safely away from young children to avoid accidental ingestion

Asmin 4mg Tablet is generally used as a long-term preventive treatment for young children and works best when given regularly as part of an overall asthma or allergy management plan agreed with the child’s doctor. Parents and caregivers should keep track of symptom frequency and any side effects, particularly changes in mood, sleep, or behaviour, and discuss these at follow-up visits so that treatment can be adjusted if needed.